China Releases New Hypertension Management Standards for Primary Healthcare Institutions: Equipment, Medication, and Procedures Fully Specified, Effective March 2026

Why Specialized Management Standards Are Needed: Addressing Key Challenges in Primary Care Prevention

China has over 300 million hypertension patients, with nearly 80% requiring long-term management at the primary care level. However, primary institutions have historically faced several shortcomings in prevention and control: some village clinics used blood pressure monitors that were not regularly calibrated, leading to measurement errors; some facilities lacked a complete range of antihypertensive drugs, disrupting treatment continuity; and inconsistent diagnostic procedures across institutions resulted in varying approaches to the same condition. These issues directly impacted blood pressure control outcomes.

An official from the National Health Commission stated that the introduction of specialized standards aims to address three major challenges in primary hypertension care: "inadequate equipment, drug shortages, and inconsistent procedures." By unifying technical requirements and clarifying service norms, the Standards enable primary institutions to "manage effectively, confidently, and competently," thereby reducing the risk of cardiovascular and cerebrovascular complications from the outset. Data indicate that standardized management of hypertensive patients can reduce stroke incidence by 30% and myocardial infarction incidence by 25%. The implementation of these Standards is expected to benefit hundreds of millions of people with hypertension.

Key Aspect One of the Standards: Clear Minimum Requirements for Equipment and Drugs to Ensure Foundational Support

The Standards first establish non-negotiable requirements for the hardware and drug inventories of primary institutions, ensuring that prevention and control efforts are guided by clear protocols.

1. Equipment Configuration: "Basic" and "Advanced" Tiers
   All primary healthcare institutions, including the smallest village clinics, must be equipped with three essential devices: an upper-arm medical electronic blood pressure monitor, a height and weight scale, and a soft tape measure. Blood pressure monitors must undergo regular calibration to ensure accurate measurements. First-tier institutions, such as community health service centers and township health centers, must additionally be equipped with devices such as blood cell analyzers, urine analyzers, blood biochemistry analyzers, and electrocardiograms to perform basic tests—including liver and kidney function, lipid profiles, and blood glucose—without requiring patients to visit higher-level hospitals.
   The 2025 Guidelines emphasize three critical aspects of blood pressure measurement: using accurate, certified electronic blood pressure monitors; ensuring the patient is quiet and relaxed (resting for 5–10 minutes before measurement); and following proper positioning (cuff center at heart level). These details help minimize measurement errors.

2. Antihypertensive Drugs: Mandatory Stock of Five Major Classes to Ensure Treatment Continuity
   Drug availability is central to hypertension management. The Standards explicitly require primary healthcare institutions to stock the five major classes of first-line antihypertensive drugs: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Blockers (ARBs), Beta-Blockers, Dihydropyridine Calcium Channel Blockers (CCBs), and Thiazide Diuretics, as well as single-pill combinations of these drugs. Institutions with adequate resources may also stock Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) to provide more options for patients with concurrent heart failure.
   This requirement addresses the previous issue of "incomplete drug formularies forcing patients to seek care elsewhere." For example, hypertensive patients with diabetes require preferential use of ACEIs or ARBs, while those with coronary heart disease need combined therapy with beta-blockers. With primary institutions fully stocked, patients can now "access medication locally and receive standardized treatment."

Key Aspect Two of the Standards: Standardized "Four-Step" Clinical Pathway, from Screening to Referral

Integrating the 2025 Guidelines, the Standards establish a comprehensive management system encompassing "screening, diagnosis, treatment, and follow-up," with clear operational criteria at each stage to prevent missed diagnoses, misdiagnoses, and non-standardized treatment.

1. Screening: Mandatory Blood Pressure Measurement for All First-Time Patients Aged 18 and Above to Expand Early Detection
   The Standards require that all adults aged 18 and above undergo blood pressure measurement during their first visit to a primary institution, enforcing the "first-visit blood pressure measurement" policy. Additionally, primary institutions must proactively identify high-risk individuals through health check-ups, community screenings, and elderly health management programs. Those with risk factors such as family history of hypertension, obesity, smoking, or long-term alcohol use should have their blood pressure measured at least once every six months.

2. Diagnosis: Clear Criteria for Three Types of Blood Pressure Measurements to Avoid Misdiagnosis of "White-Coat Hypertension"
   For the first time at the primary care level, the Standards unify diagnostic criteria for three types of blood pressure measurements:

   • Office Blood Pressure: Diagnosis confirmed if readings are ≥140/90 mmHg on three separate days within four weeks.

   • Home Blood Pressure: Diagnosis confirmed if the average value is ≥135/85 mmHg (based on measurements taken twice daily—morning and evening—for 3–7 consecutive days).

   • Ambulatory Blood Pressure: Diagnosis confirmed if the 24-hour average is ≥130/80 mmHg, or the daytime average is ≥135/85 mmHg, or the nighttime average is ≥120/70 mmHg.
     Patients with first-visit blood pressure ≥180/110 mmHg and symptoms require immediate referral. For asymptomatic patients, diagnosis is confirmed if readings remain high after rest. If "white-coat hypertension" (high in clinic, normal at home) or "masked hypertension" (normal in clinic, high at home) is suspected, institutions with resources should perform ambulatory blood pressure monitoring; otherwise, referral is required for further evaluation.

3. Treatment: Three Principles—"Target Achievement, Stability, and Comprehensive Management"—Aiming for Control Within Three Months
   Hypertension treatment should follow three core principles: First, achieving blood pressure targets: <130/80 mmHg for patients under 80 years old; <150/90 mmHg for patients aged 80 and above (or <140/90 mmHg if tolerated). Second, ensuring stable reduction: long-acting medications are prioritized to avoid blood pressure fluctuations. Third, implementing comprehensive management: patients with concurrent hyperlipidemia or hyperglycemia require simultaneous intervention, including lipid-lowering or antiplatelet medications when necessary.
   The Standards specify that diagnosed patients must immediately begin lifestyle interventions, encapsulated as the "Eight Steps to a Healthy Lifestyle": salt restriction, weight management, increased physical activity, smoking cessation, alcohol moderation, stress reduction, balanced nutrition, and adequate sleep. Regarding drug therapy, except for low-risk, mild cases who may undergo lifestyle intervention alone for three months, all other patients require concurrent medication and should achieve target blood pressure within three months.

4. Follow-Up: Tiered Management and Mandatory Referral for Five Patient Types to Prevent Risk Oversight
   Primary institutions must implement tiered follow-up for patients: every three months for those with stable,达标 blood pressure, and every 2–4 weeks for those not meeting targets. Follow-up should include blood pressure measurement, medication review, and lifestyle counseling. Special attention must be given to identifying five types of patients requiring referral:

   • Sudden onset with severe symptoms (e.g., severe headache, blurred vision).

   • Suspected secondary hypertension (e.g., episodic headaches, muscle weakness).

   • Difficult-to-control blood pressure (not meeting targets despite using three drugs).

   • Concurrent severe complications (e.g., heart failure, stroke).

   • Pregnant women with hypertension.
     Patients diagnosed and stabilized at higher-level hospitals should be promptly referred back to primary institutions for follow-up management, forming a closed-loop "two-way referral" system.

How Residents Benefit: Remember Three Key Points to Make the Most of Primary Care Resources

The implementation of the Standards will transform the management experience for hypertensive patients. Residents need only remember the following three points to better access standardized services:

1. Actively Participate in Screening; Measure Blood Pressure Accurately at Home
   Individuals aged 18 and above should comply with first-visit blood pressure measurement. High-risk groups should perform regular self-checks. For home measurement, use a certified electronic blood pressure monitor. Avoid smoking or consuming caffeine before measuring. Rest for five minutes in a seated position. Measure consecutively for three days and average the results for greater reliability.

2. Follow Medical Advice for Treatment; Do Not Alter or Discontinue Medication Without Guidance
   After diagnosis, strictly adhere to the "lifestyle intervention + drug therapy" plan. Primary institutions now stock the five major drug classes. Discuss with your healthcare provider to choose a suitable regimen (e.g., ACEIs or ARBs for those with kidney disease, diuretics for those with edema). Continue medication even after blood pressure is controlled, as abrupt discontinuation may lead to rebound hypertension.

3. Seek Timely Referral for Abnormalities; Do Not Delay Care
   If symptoms such as sudden blood pressure spikes, chest pain, or limb numbness occur, or if side effects like dry cough or edema develop after starting medication, visit a primary institution immediately. If referral criteria are met, proceed promptly to a higher-level hospital to avoid delays in treatment.

More Competent Primary Care "Gatekeepers," Greater Confidence in Hypertension Management

The introduction of the Management Standards for Hypertension Prevention and Control in Primary Healthcare Institutions provides primary institutions with a clear "operational manual" and offers hypertensive patients more reliable "health gatekeepers." Starting March 2026, unified standards will govern everything from blood pressure measurement in village clinics to drug therapy in community health service centers. For residents, actively participating in screening and receiving standardized management means access to high-quality hypertension prevention and treatment services close to home. This truly advances the goal of "early detection, early treatment, and fewer complications," safeguarding public health.

This article is curated from external sources and published by CHN Healthcare Network. The views expressed do not necessarily reflect the platform’s position. For copyright concerns regarding content or images, please contact us at info@healthcarechn.com for prompt resolution.